Lv0
0 积分 2025-01-03 加入
Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets
2个月前
已完结
LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb study
3个月前
已完结
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis
4个月前
已完结
皖公网安备34019202002308
